BioCryst Pharmaceuticals
BCRX
BCRX
103 hedge funds and large institutions have $248M invested in BioCryst Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 29 reducing their positions, and 10 closing their positions.
Holders
103
Holders Change
+3
Holders Change %
+3%
% of All Funds
2.75%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
13
Increased
29
Reduced
29
Closed
10
Calls
$5.36M
Puts
$5.71M
Net Calls
-$348K
Net Calls Change
-$548K
Top Buyers
1 |
DM
1
Deerfield Management
New York
|
$19.4M |
2 |
RI
2
RTW Investments
New York
|
$18.5M |
3 |
ACA
3
Avoro Capital Advisors
New York
|
$6.08M |
4 |
4
Invesco
Atlanta,
Georgia
|
$4.27M |
5 |
ACP
5
Acuta Capital Partners
Redwood City,
California
|
$2.45M |